Filing Details
- Accession Number:
- 0000059478-17-000249
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-13 15:01:40
- Reporting Period:
- 2017-12-11
- Accepted Time:
- 2017-12-13 15:01:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 59478 | Lilly Eli & Co | LLY | Pharmaceutical Preparations (2834) | 350470950 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1479079 | N Jeffrey Simmons | Lilly Corporate Center Indianapolis IN 46285 | Svp&Pres. Elanco Animal Health | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-12-11 | 12,500 | $86.46 | 124,522 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-05-22 | 6,390 | $0.00 | 118,132 | No | 5 | G | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 5 | G | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,074 | Indirect | 401(k) |
Footnotes
- The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2017.
- This transaction was executed in multiple trades at prices ranging from $86.09 to $86.65. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
